![The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura, The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,](https://journals.sagepub.com/cms/10.1177/14799731231166008/asset/images/large/10.1177_14799731231166008-fig2.jpeg)
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png)
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
![Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram](https://www.researchgate.net/publication/347420613/figure/tbl1/AS:986275486109704@1612157808803/Long-Acting-Muscarinic-Receptor-Antagonists-LAMA-in-Clinical-Development.png)
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Breathe Better on X: "If your doctor prescribes a long-acting muscarinic antagonist (LAMA) with an inhaled corticosteroid, make sure they explain how to use the inhaler properly because it's different than those
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table3-1.png)
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
![SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download](https://images.slideplayer.com/26/8900224/slides/slide_3.jpg)
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download
![Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram](https://www.researchgate.net/publication/49628996/figure/fig1/AS:305844810993666@1449930493787/Algorithm-showing-use-of-inhaled-therapies-FEV-1-forced-expiratory-volume-in-1-s-ICS.png)
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
![Inhaled long-acting muscarinic antagonists in asthma – A narrative review - European Journal of Internal Medicine Inhaled long-acting muscarinic antagonists in asthma – A narrative review - European Journal of Internal Medicine](https://www.ejinme.com/cms/asset/15c03116-85a9-4214-bbc9-2bef5e60c097/gr3.jpg)
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - European Journal of Internal Medicine
![The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society](https://err.ersjournals.com/content/errev/31/164/210196/F3.large.jpg)
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
![Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society](https://openres.ersjournals.com/content/erjor/5/3/00106-2019/F1.large.jpg)
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
![Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7d4f4e31-6a4d-4e62-bf76-ac345654f628/all14766-fig-0003-m.jpg)